Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Gene screening technology developed at Harvard Medical School licensed to Versicor

Aug. 10, 1998

Label expansion for CEPRATE SC approved

July 31, 1998

Alizyme granted exclusive worldwide license to BTG drug delivery technology

July 31, 1998

Multiyear drug delivery agreement signed by Bioglan and Novo Nordisk

July 28, 1998

Hybridon and Searle extend and expand antisense research collaboration

July 28, 1998

Fuisz and Novopharm enter agreements for CEFORM CR technology

July 28, 1998

Millennium, Wyeth-Ayerst identify another CNS gene target

July 28, 1998

AxyS elucidates 3-D structure of cathepsin S

July 27, 1998

Fuisz and AHP agreement for CEFORM EA technology

July 24, 1998

Genzyme Transgenics and Lilly to develop novel transgenic protein

July 24, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...